José Antonio Matus
José Antonio Matus is a Mexican lawyer and coordinator of the HIV Healthcare Foundation (AHF) in Mexico. He has been vocal about the challenges faced by Latin American countries in accessing innovative HIV treatments, specifically highlighting the exclusion of Lenacapavir from a pricing agreement between Gilead Sciences and the Global Fund. Matus has emphasized that this lack of access leads to increased healthcare costs and hinders the fight against HIV in Mexico, where the number of diagnosed cases is on the rise.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Guatemala | 1 | 5.00 | 0.09% | +0% | 17,915,568 | 16,791 | $82,000 | 77$ |
| Panama | 1 | 6.00 | 0.10% | +0% | 4,314,768 | 4,293 | $76,000 | 76$ |
| Totals | 2 | 22,230,336 | 21,084 | $158,000 | 153$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Guatemala:
José Antonio Matus is a lawyer who warns about the exclusion of Latin America from a pricing agreement for lenacapavir.
5
Panama:
José Antonio Matus is a Mexican lawyer who highlighted the exclusion of Latin America from a pricing agreement for Lenacapavir.
6